Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Allergy and Asthma Reports
Erschienen in: Current Allergy and Asthma Reports 11/2016

01.11.2016 | Pediatric Allergy and Immunology (W Dolen, Section Editor)

Immune Responses in Rhinovirus-Induced Asthma Exacerbations

verfasst von: John W. Steinke, Larry Borish

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Acute asthma exacerbations are responsible for urgent care visits and hospitalizations; they interfere with school and work productivity, thereby driving much of the morbidity and mortality associated with asthma. Approximately 80 to 85 % of asthma exacerbations in children, adolescents, and less frequently adults are associated with viral upper respiratory tract viral infections, and rhinovirus (RV) accounts for ∼60–70 % of these virus-associated exacerbations. Evidence suggests that it is not the virus itself but the nature of the immune response to RV that drives this untoward response. In particular, evidence supports the concept that RV acts to exacerbate an ongoing allergic inflammatory response to environmental allergens present at the time of the infection. The interaction of the ongoing IgE- and T cell-mediated response to allergen superimposed on the innate and adaptive immune responses to the virus and how this leads to triggering of an asthma exacerbation is discussed.
Literatur
1.
Denlinger LC, Sorkness RL, Lee WM, et al. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation. Am J Respir Crit Care Med. 2011;184:1007–14.CrossRefPubMedPubMedCentral
2.
Moore WC, Hastie AT, Li X, et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol. 2014;133:1557–63. e5.CrossRefPubMed
3.
Kantor DB, Stenquist N, McDonald MC, et al. Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children. J Allergy Clin Immunol 2016.
4.
Johnston SL, Pattemore PK, Sanderson G, et al. Community study of the role of viral infections in exacerbations of asthma in 9–11 year old children. Brit Med J. 1995;310:1225–9.CrossRefPubMedPubMedCentral
5.
6.
Johnston SL, Pattemore PK, Sanderson G, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med. 1996;154:654–60.CrossRefPubMed
7.
Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol. 2005;115:132–8.CrossRefPubMed
8.
Kling S, Donninger H, Williams Z, et al. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy. 2005;35:672–8.CrossRefPubMed
9.
Khetsuriani N, Kazerouni NN, Erdman DD, et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol. 2007;119:314–21.CrossRefPubMed
10.
Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006;61:376–82.CrossRefPubMed
11.
12.
Wos M, Sanak M, Soja J, et al. The presence of rhinovirus in lower airways of patients with bronchial asthma. Am J Respir Crit Care Med. 2008;177:1082–9.CrossRefPubMedPubMedCentral
13.•
Miller EK, Linder J, Kraft DJ, et al. Hospitalizations and outpatient visits for rhinovirus-associated acute respiratory illness in adults. J Allergy Clin Immunol. 2016;137:734–43 e1. This article added to the body of literature demonstrating the association of RV infection with asthma exacerbations. The unique aspect was the focus on the adult population rather than children as has previously been shown.CrossRefPubMed
14.
Heymann PW, Carper HT, Murphy DD, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol. 2004;114:239–47.CrossRefPubMed
15.
Soto-Quiros M, Avila L, Platts-Mills TA, et al. High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus. J Allergy Clin Immunol. 2012;129:1499–1505.e5.CrossRefPubMedPubMedCentral
16.
17.
Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364:1005–15.CrossRefPubMedPubMedCentral
18.••
Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136:1476–85. As a follow-up study, this report further demonstrated the ability of treatment with omalizumab (anti-IgE) to prevent asthma exacerbations during the fall allergy season. It suggests that blocking the underlying allergic reaction can inhibit the synergistic effect of RV infection that results in a severe asthma exacerbation.CrossRefPubMed
19.
20.
Peltola V, Waris M, Osterback R, et al. Clinical effects of rhinovirus infections. J Clin Virol. 2008;43:411–4.CrossRefPubMed
21.
Palmenberg AC, Spiro D, Kuzmickas R, et al. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science. 2009;324:55–9.CrossRefPubMedPubMedCentral
22.
Hamparian VV, Colonno RJ, Cooney MK, et al. A collaborative report: rhinoviruses—extension of the numbering system from 89 to 100. Virology. 1987;159:191–2.CrossRefPubMed
23.
Lamson D, Renwick N, Kapoor V, et al. MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004–2005. J Infect Dis. 2006;194:1398–402.CrossRefPubMed
24.
Oliveira MA, Zhao R, Lee WM, et al. The structure of human rhinovirus 16. Structure. 1993;1:51–68.CrossRefPubMed
25.
26.
Vlasak M, Roivainen M, Reithmayer M, et al. The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding. J Virol. 2005;79:7389–95.CrossRefPubMedPubMedCentral
27.
Whiteman SC, Bianco A, Knight RA, et al. Human rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 (ICAM-1) receptor to promote epithelial cell infectivity. J Biol Chem. 2003;278:11954–61.CrossRefPubMed
28.
Bochkov YA, Palmenberg AC, Lee WM, et al. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat Med. 2011;17:627–32.CrossRefPubMedPubMedCentral
29.••
Bochkov YA, Watters K, Ashraf S, et al. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc Natl Acad Sci U S A. 2015;112:5485–90. RV serotype C had been identified but did not use the same receptors for entry as A or B. This gene that was previous identifed through genetic association studies to be associated with childhood asthma was shown to be the receptor used by RV serotype C. The work also demonstrated the need for differentiated epithelial cells in order for the virus to propagate.
30.
Zambrano JC, Carper HT, Rakes GP, et al. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE. J Allergy Clin Immunol. 2003;111:1008–16.CrossRefPubMed
31.
Turner RB, Weingand KW, Yeh CH, et al. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis. 1998;26:840–6.CrossRefPubMed
32.
Proud D, Turner RB, Winther B, et al. Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. Am J Respir Crit Care Med. 2008;178:962–8.CrossRefPubMed
33.
Gwaltney Jr JM, Phillips CD, Miller RD, et al. Computed tomographic study of the common cold. N Eng J Med. 1994;330:25–30.CrossRef
34.
Las Heras J, Swanson VL. Sudden death of an infant with rhinovirus infection complicating bronchial asthma: case report. Pediatr Pathol. 1983;1:319–23.CrossRefPubMed
35.
Collinson J, Nicholson KG, Cancio E, et al. Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax. 1996;51:1115–22.CrossRefPubMedPubMedCentral
36.
Nicholson KG, Kent J, Hammersley V, et al. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study. BMJ. 1996;313:1119–23.CrossRefPubMedPubMedCentral
37.
Folkerts G, Busse WW, Nijkamp FP, et al. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med. 1998;157:1708–20.CrossRefPubMed
38.
Papadopoulos NG, Bates PJ, Bardin PG, et al. Rhinoviruses infect the lower airways. J Infect Dis. 2000;181:1875–84.CrossRefPubMed
39.
Message SD, Laza-Stanca V, Mallia P, et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A. 2008;105:13562–7.CrossRefPubMedPubMedCentral
40.
Beale J, Jayaraman A, Jackson DJ, et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med. 2014;6:256ra134.CrossRefPubMedPubMedCentral
41.
Jackson DJ, Makrinioti H, Rana BM, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014;190:1373–82.CrossRefPubMedPubMedCentral
42.
Killington RA, Stott EJ, Lee D. The effect of temperature on the synthesis of rhinovirus type 2 RNA. J Gen Virol. 1977;36:403–11.CrossRefPubMed
43.
Gern JE, Galagan DM, Jarjour NN, et al. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med. 1997;155:1159–61.CrossRefPubMed
44.
Bentley JK, Sajjan US, Dzaman MB, et al. Rhinovirus colocalizes with CD68- and CD11b-positive macrophages following experimental infection in humans. J Allergy Clin Immunol. 2013;132:758–61. e3.CrossRefPubMedPubMedCentral
45.
Papadopoulos NG, Sanderson G, Hunter J, et al. Rhinoviruses replicate effectively at lower airway temperatures. J Med Virol. 1999;58:100–4.CrossRefPubMed
46.
Winther B, Gwaltney JM, Hendley JO. Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis. 1990;141:839–45.CrossRefPubMed
47.
Juncadella IJ, Kadl A, Sharma AK, et al. Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature. 2013;493:547–51.CrossRefPubMed
48.
Sajjan U, Wang Q, Zhao Y, et al. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med. 2008;178:1271–81.CrossRefPubMedPubMedCentral
49.
Yeo NK, Jang YJ. Rhinovirus infection-induced alteration of tight junction and adherens junction components in human nasal epithelial cells. Laryngoscope. 2010;120:346–52.PubMed
50.
Rezaee F, Meednu N, Emo JA, et al. Polyinosinic:polycytidylic acid induces protein kinase D-dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells. J Allergy Clin Immunol. 2011;128:1216–24. e11.CrossRefPubMedPubMedCentral
51.••
Kennedy JL, Shaker M, McMeen V, et al. Comparison of viral load in individuals with and without asthma during infections with rhinovirus. Amer J Respir Crit Care Med. 2014;189:532–9. It was previously thought that asthmatics would have higher viral loads when infected and that this leads to the increased susceptibility to asthma exacerbations. Using several cohorts, it was shown that the viral titers in asthmatics and non-asthmatics were the same.CrossRef
52.
Ngamtruakulpanit LVJ, Nguyen A, Urban P, et al. Exhaled breath condensate acidification during rhinovirus colds. American Thoracic Society 99th International Coference, Seattle 2003.
53.
Slater L, Bartlett NW, Haas JJ, et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog. 2010;6:e1001178.CrossRefPubMedPubMedCentral
54.
Triantafilou K, Vakakis E, Richer EA, et al. Human rhinovirus recognition in non-immune cells is mediated by Toll-like receptors and MDA-5, which trigger a synergetic pro-inflammatory immune response. Virulence. 2011;2:22–9.CrossRefPubMedPubMedCentral
55.
Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006;12:1023–6.CrossRefPubMed
56.
Miller EK, Hernandez JZ, Wimmenauer V, et al. A mechanistic role for type III IFN-lambda1 in asthma exacerbations mediated by human rhinoviruses. Am J Respir Crit Care Med. 2012;185:508–16.CrossRefPubMedPubMedCentral
57.
Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201:937–47.CrossRefPubMedPubMedCentral
58.
Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood. 2001;97:14–32.CrossRefPubMed
59.
Laza-Stanca V, Message SD, Edwards MR, et al. The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations. PLoS Pathog. 2011;7:e1002114.CrossRefPubMedPubMedCentral
60.
Einarsson O, Geba GP, Zhu Z, et al. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest. 1996;97:915–24.CrossRefPubMedPubMedCentral
61.
Jarjour NN, Gern JE, Kelly EA, et al. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol. 2000;105:1169–77.CrossRefPubMed
62.
63.
Gern JE, Vrtis R, Grindle KA, et al. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med. 2000;162:2226–31.CrossRefPubMed
64.
Avila PC, Abisheganaden JA, Wong H, et al. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold. J Allergy Clin Immunol. 2000;105:923–32.CrossRefPubMed
65.
Commins SP, Borish L, Steinke JW. Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol. 2010;125:S53–72.CrossRefPubMed
66.
Nino G, Huseni S, Perez GF, et al. Directional secretory response of double stranded RNA-induced thymic stromal lymphopoetin (TSLP) and CCL11/eotaxin-1 in human asthmatic airways. PLoS One. 2014;9:e115398.CrossRefPubMedPubMedCentral
67.
Perez GF, Pancham K, Huseni S, et al. Rhinovirus infection in young children is associated with elevated airway TSLP levels. Eur Respir J. 2014;44:1075–8.CrossRefPubMedPubMedCentral
68.••
Muehling LM, Mai DT, Kwok WW, et al.: Circulating Memory CD4+ T Cells Target Conserved Epitopes of Rhinovirus Capsid Proteins and Respond Rapidly to Experimental Infection in Humans. J Immunol 2016. Using epitope guided mapping, conserved regions common to RV were identified and MHC class II tetramers were made. Following RV challenge of non-asthmatic subjects, memory T cells were identfied in these patients that increased in number and displayed activation markers in the days after infection.
69.••
Steinke JW, Liu L, Turner RB, et al. Immune surveillance by rhinovirus-specific circulating CD4+ and CD8+ T lymphocytes. PLoS One. 2015;10:e0115271. Using a dendritic cell:T cell coculture system in which RV was presented by the dendritic cells, circulating CD4+ and CD8+ T cells were identified that could expand and produce cytokines. These results suggest memory cells are circulating that are acting in immune surveilleance allowing rapid response when RV viral infection is detected.CrossRefPubMedPubMedCentral
70.
Gern JE, Dick EC, Kelly EA, et al. Rhinovirus-specific T cells recognize both shared and serotype-restricted viral epitopes. J Infect Dis. 1997;175:1108–14.CrossRefPubMed
71.
Duff AL, Pomeranz ES, Gelber LE, et al. Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics. 1993;92:535–40.PubMed
72.
Green RM, Custovic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case–control study. BMJ. 2002;324:763.CrossRefPubMedPubMedCentral
73.
Metadaten
Titel
Immune Responses in Rhinovirus-Induced Asthma Exacerbations
verfasst von
John W. Steinke
Larry Borish
Publikationsdatum
01.11.2016
Verlag
Springer US
Erschienen in
Current Allergy and Asthma Reports / Ausgabe 11/2016
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-016-0661-2

Weitere Artikel der Ausgabe 11/2016

Current Allergy and Asthma Reports 11/2016 Zur Ausgabe

Immunologic/Diagnostic Tests in Allergy (M Chapman and A Pomés, Section Editors)

How In Vitro Assays Contribute to Allergy Diagnosis

Asthma (WJ Calhoun and V Ortega, Section Editors)

The Reemergence of the Asthma-COPD Overlap Syndrome: Characterizing a Syndrome in the Precision Medicine Era

Occupational Allergies (JA Poole, Section Editor)

Occupational Respiratory Allergic Diseases in Healthcare Workers

Asthma (WJ Calhoun and V Ortega, Section Editors)

Interleukin-5 Antagonists Usher in a New Generation of Asthma Therapy

Basic and Applied Science (I Lewkowich, Section Editor)

Immunoglobulin Glycosylation Effects in Allergy and Immunity

Neu im Fachgebiet HNO

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise